Citation of paper, Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Janin Nouhin1337597.7
Sven Stegemann1253842.5
Yaseen A M M El-Shaier1426365.5
Hanan Elimam1212042.9
Friderike Weege1413017.1
Marcel Alexander Müller113730,61684.6
Yassmin Moatasim1346856.9
Jakob Trimpert13879514.4
Robin Polt1992,8291.8
Jan Papies1838927.9
Nikolaus Osterrieder12518,2754.8
Nils Christian Gassen1525,91622.3
Kevin Dhaliwal1922,9445.6
Victor M Corman123023,59245.3
Scott V Jermain11035010.3
Ahmed Mostafa1911,4586.3
Markus Morkel1321,1826.4
David Needham11089,0844.3
Roland Eils143640,26413.8
Khaled A M Abouzid11032,1833.3
Frank L Heppner117416,74713.9
Mohammed F El-Behairy1312021.2
Daniel E Heinz1122117.9
Christian Conrad1293,37063.9
Robert Lorenz Chua1121,99799.9
Marwa A A Fayed1221092

Journals Citing This Paper

JournalCiting PapersJournal's IFJournal's Star
Pharmaceutics26.4
International Journal of Pharmaceutics: X13.2
SLAS Discovery13.4★★
Clinical Microbiology Reviews134★★
Advanced Drug Delivery Reviews118.5★★
Molecular Biology Reports12.8★★
Nature Communications117.4
RSC Advances13.7★★